Nucleic Acid Delivery with α-Tocopherol-Polyethyleneimine-Polyethylene Glycol Nanocarrier System

por Hossian, A K M Nawshad, Jois, Seetharama D, Jonnalagadda, Subash C, Mattheolabakis, George
Publicado 2020

Past, Present, and a Glance into the Future of Multiple Myeloma Treatment

por Elbezanti, Weam Othman, Challagundla, Kishore B., Jonnalagadda, Subash C., Budak-Alpdogan, Tulin, Pandey, Manoj K.
Publicado 2023

Hydrogel-Encapsulated Heterogenous Mesoporous Resin Catalyst for In Situ Anti-Cancer Agent Production under Biological Conditions

por Nabavinia, Mahboubeh, Kanjilal, Baishali, Pandey, Manoj, Jonnalagadda, Subash, Hesketh, Robert, Martins-Green, Manuela, Noshadi, Iman
Publicado 2022

Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity

por Fultang, Norman, Illendula, Abhinav, Chen, Brian, Wu, Chun, Jonnalagadda, Subash, Baird, Nathan, Klase, Zachary, Peethambaran, Bela
Publicado 2019

Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma

por Al-Odat, Omar S., Guirguis, Daniel A., Schmalbach, Nicole K., Yao, Gabriella, Budak-Alpdogan, Tulin, Jonnalagadda, Subash C., Pandey, Manoj K.
Publicado 2022

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

por Al-Odat, Omar S., von Suskil, Max, Chitren, Robert J., Elbezanti, Weam O., Srivastava, Sandeep K., Budak-Alpddogan, Tulin, Jonnalagadda, Subash C., Aggarwal, Bharat B., Pandey, Manoj
Publicado 2021

Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents

por Solano, Lucas N., Nelson, Grady L., Ronayne, Conor T., Jonnalagadda, Shirisha, Jonnalagadda, Sravan K., Kottke, Kaija, Chitren, Robert, Johnson, Joseph L., Pandey, Manoj K., Jonnalagadda, Subash C., Mereddy, Venkatram R.
Publicado 2020

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma

por Von Suskil, Max, Sultana, Kazi Nasrin, Elbezanti, Weam Othman, Al-Odat, Omar S., Chitren, Robert, Tiwari, Amit K., Challagundla, Kishore B., Srivastava, Sandeep Kumar, Jonnalagadda, Subash C., Budak-Alpdogan, Tulin, Pandey, Manoj K.
Publicado 2021

Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cell...

por Elbezanti, Weam Othman, Al-Odat, Omar S., Chitren, Robert, Singh, Jaikee Kumar, Srivastava, Sandeep Kumar, Gowda, Krishne, Amin, Shantu, Robertson, Gavin P., Nemmara, Venkatesh V., Jonnalagadda, Subash C., Budak-Alpdogan, Tulin, Pandey, Manoj K.
Publicado 2022